Harmony Biosciences Holdings, Inc.
NASDAQ:HRMY
38.99 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 311.66 | 243.784 | 234.309 | 228.631 | 24.457 | 83.523 |
| Short Term Investments
| 41.8 | 79.331 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 353.46 | 323.115 | 234.309 | 228.631 | 24.457 | 83.523 |
| Net Receivables
| 74.14 | 54.74 | 34.843 | 22.176 | 4.255 | 0 |
| Inventory
| 5.363 | 4.297 | 4.432 | 3.823 | 1.088 | 0 |
| Other Current Assets
| 5.537 | 8.786 | 3.218 | 1.302 | 0.261 | 2.458 |
| Total Current Assets
| 451.07 | 400.285 | 284.439 | 262.891 | 31.497 | 86.684 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 0.371 | 0.573 | 0.82 | 0.938 | 1.33 | 1.576 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 137.108 | 160.953 | 143.919 | 162.343 | 72.185 | 0 |
| Goodwill and Intangible Assets
| 137.108 | 160.953 | 143.919 | 162.343 | 72.185 | 0 |
| Long Term Investments
| 72.169 | 22.568 | 0.75 | 0.75 | 0.75 | 0.5 |
| Tax Assets
| 144.162 | 85.943 | -0.75 | -0.75 | -0.75 | 0 |
| Other Non-Current Assets
| 6.568 | 3.548 | 4.265 | 0.902 | 1.691 | 0.522 |
| Total Non-Current Assets
| 360.378 | 273.585 | 149.004 | 164.183 | 75.206 | 2.598 |
| Total Assets
| 811.448 | 673.87 | 433.443 | 427.074 | 106.703 | 89.282 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 17.73 | 3.786 | 1.001 | 2.556 | 6.36 | 1.462 |
| Short Term Debt
| 15 | 2 | 2 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 123.241 | 0 | 49.414 | 0 | 0 | 0 |
| Other Current Liabilities
| 7.81 | 73.098 | 1.36 | 131.983 | 13.532 | 5.769 |
| Total Current Liabilities
| 163.781 | 78.884 | 53.775 | 134.539 | 19.892 | 7.231 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 178.566 | 189.647 | 189.984 | 194.25 | 97.946 | 324.201 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0.212 | 0.287 | 0.262 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | -0.212 | -0.287 | -324.463 |
| Other Non-Current Liabilities
| 2.109 | 2.501 | 3.177 | 1.105 | 0.45 | 0.523 |
| Total Non-Current Liabilities
| 180.675 | 192.148 | 193.161 | 195.355 | 98.396 | 0.523 |
| Total Liabilities
| 344.456 | 271.032 | 246.936 | 329.894 | 118.288 | 7.754 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 427.074 | 411.277 | 324.201 |
| Common Stock
| 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
| Retained Earnings
| -143.277 | -272.13 | -453.598 | -488.195 | -422.862 | -242.673 |
| Accumulated Other Comprehensive Income/Loss
| 0.002 | -0.151 | -0 | -427.074 | -0.002 | -0.002 |
| Other Total Stockholders Equity
| 610.266 | 675.118 | 640.104 | 585.374 | 0.001 | 0.001 |
| Total Shareholders Equity
| 466.992 | 402.838 | 186.507 | 97.18 | -11.585 | 81.528 |
| Total Equity
| 466.992 | 402.838 | 186.507 | 97.18 | -11.585 | 81.528 |
| Total Liabilities & Shareholders Equity
| 811.448 | 673.87 | 433.443 | 427.074 | 106.703 | 89.282 |